Bioprocess Automation Market Report 2024 - Market Size, Growth Rate, Major Drivers And Key Trends | F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Corporation, Danaher Corporation

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Bioprocess Automation Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $9.10 billion In 2028 At A CAGR Of 12.5% :

The bioprocess automation market size has grown rapidly in recent years. It will grow from $5.01 billion in 2023 to $5.67 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to increased efficiency, cost reduction, risk mitigation, rising demand for remote monitoring and control, and reduced labor dependency.

The bioprocess automation market size is expected to see rapid growth in the next few years. It will grow to $9.10 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to enhanced productivity, regulatory compliance, process optimization, predictive maintenance predictive maintenance, and real-time analytics. Major trends in the forecast period include integration of ai and machine learning, modular bioprocessing, process control strategies for gene therapy, process control strategies for gene therapy, and data analytics and visualization.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=14058&type=smp

Bioprocess Automation Market Major Segments
The bioprocess automation market covered in this report is segmented -

1) By Component Of Process Control System: Sensors, Actuators, Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations
3) By Mode Of Operation: Batch, Fed-Batch, Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems

Key Driver - The Role Of Personalized Medicine In Driving Bioprocess Automation Market Growth

The increasing number of personalized medicines is expected to fuel the growth of the bioprocess automation market going forward. Personalized medicine refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to the individual characteristics of each patient. Bioprocess automation helps personalized medicine by enabling precision and scalability in producing patient-specific drugs. For instance, according to Personalized Medicine Coalition, a US-based professional membership organization, in 2022, approving 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the increasing number of personalized medicines is driving the growth of the bioprocess automation market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=14058&type=smp

Prominent Trend - Innovative Bioreactor Solutions Revolutionizing Bioprocessing Operations

Major companies operating in the bioprocess automation market are developing innovative solutions, such as bioreactors to simplify bioprocessing operations. A bioreactor is an engineered system or device that provides an optimal and controlled environment for biological and chemical reactions. For instance, in April 2023, Cytiva, a US-based technology company that provides technologies and services that help advance and accelerate the development and manufacture of therapeutics, launched X-platform bioreactors to simplify single-use upstream bioprocessing operations. It is easy to operate, flexible, and more efficient in the process. It was first offered in 50 and 200 L capacities. They can increase process efficiency through ergonomic improvements, production capability, and simplified supply chain operations. The X-platform bioreactors can be used to manufacture cell and gene therapies as well as viral vectors, in addition to monoclonal antibodies (mAbs).

Bioprocess Automation Market Players
Major companies operating in the bioprocess automation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Corporation, Danaher Corporation, Amgen Inc., Merck KGaA , Parker-Hannifin Corporation, CSL Behring LLC, Rockwell Automation Inc., Agilent Technologies Inc. , Lonza Group AG, Waters Corporation , Getinge AB, Eppendorf AG, Repligen Corporation, BIONET Research S.A., Flotek Industries Inc., Pierre Guerin SAS, Bioengineering AG, Genedata AG, ILS Automation, INFORS AG , Synthace Limited, Automated Control Concepts Inc., BlueSens gas sensor GmbH, DISTek Integration Inc., Securecell AG, Flownamics Analytical Instruments Inc., Inscripta Inc., PendoTECH Inc., Sartorius Stedim Biotech S.A.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the bioprocess automation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Bioprocess Automation Market Report Structure
3. Bioprocess Automation Market Trends And Strategies
4. Bioprocess Automation Market - Macro Economic Scenario
5. Bioprocess Automation Market Size And Growth
…..
27. Bioprocess Automation Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.